Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:AMCI

AMCI Acquisition (AMCI) Stock Price, News & Analysis

AMCI Acquisition logo

About AMCI Acquisition Stock (NASDAQ:AMCI)

Key Stats

Today's Range
$24.59
$26.57
50-Day Range
$12.27
$16.81
52-Week Range
$9.85
$19.21
Volume
8,148 shs
Average Volume
612,576 shs
Market Capitalization
$511.91 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive AMCI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for AMCI Acquisition and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

AMCI Stock News Headlines

Is *BSEM* Oversold??
BioStem Technologies Inc. (OTC: BSEM) is emerging as one of the most exciting MedTech stories of 2025. The company delivered record-breaking revenues in 2024 and Q1 2025, including $72.5 million in net revenue for Q1 — a 73% increase over the prior year — and six consecutive quarters of positive adjusted EBITDA. With cash reserves rising to $30.8 million and a growing patent portfolio of 58 issued and 68 pending patents, BSEM is scaling profitably while advancing its proprietary BioREtain® technology, which has shown clinically superior results for chronic, non-healing wounds. National recognition is adding to the momentum, with CEO Jason Matuszewski named EY Entrepreneur of the Year 2025 Florida Award winner, validating the leadership driving this high-growth MedTech powerhouse.tc pixel
See More Headlines

AMCI Stock Analysis - Frequently Asked Questions

Based on aggregate information from My MarketBeat watchlists, some other companies that AMCI Acquisition investors own include NVIDIA (NVDA), Meta Platforms (META), Aphria (APHA), Canopy Growth (CGC), Advanced Micro Devices (AMD) and Foley Trasimene Acquisition Corp. II (BFT).

Company Calendar

Today
10/16/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Industrial organic chemicals
Sub-Industry
N/A
Current Symbol
NASDAQ:AMCI
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.07
Quick Ratio
0.07

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
$0.01 per share
Price / Cash Flow
4,094.87
Book Value
($0.56) per share
Price / Book
-47.34

Miscellaneous

Outstanding Shares
19,310,000
Free Float
14,098,000
Market Cap
$511.91 million
Optionable
Not Optionable
Beta
0.03
The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

This page (NASDAQ:AMCI) was last updated on 10/16/2025 by MarketBeat.com Staff
From Our Partners